vs
Acadia Healthcare Company, Inc.（ACHC）与越洋钻探（RIG）财务数据对比。点击上方公司名可切换其他公司
越洋钻探的季度营收约是Acadia Healthcare Company, Inc.的1.3倍（$1.0B vs $829.0M），越洋钻探净利率更高（2.4% vs 0.5%，领先1.9%），越洋钻探同比增速更快（9.6% vs 7.5%），过去两年越洋钻探的营收复合增速更高（16.9% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
越洋钻探（Transocean Ltd.）是按营收计全球规模最大的海上钻探承包商，总部位于瑞士施泰因豪森，起源于美国，目前在加拿大、美国、挪威、英国、印度、巴西、新加坡等20个国家设有办事机构，业务覆盖全球主要海上油气开采区域。
ACHC vs RIG — 直观对比
营收规模更大
RIG
是对方的1.3倍
$829.0M
营收增速更快
RIG
高出2.0%
7.5%
净利率更高
RIG
高出1.9%
0.5%
两年增速更快
RIG
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.0B |
| 净利润 | $4.5M | $25.0M |
| 毛利率 | — | 42.0% |
| 营业利润率 | — | 23.0% |
| 净利率 | 0.5% | 2.4% |
| 营收同比 | 7.5% | 9.6% |
| 净利润同比 | -50.8% | 257.1% |
| 每股收益（稀释后） | $0.05 | $0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCRIG
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $988.0M | ||
| Q1 25 | $770.5M | $906.0M | ||
| Q4 24 | $774.2M | $952.0M | ||
| Q3 24 | $815.6M | $948.0M | ||
| Q2 24 | $796.0M | $861.0M |
净利润ACHCRIG
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $25.0M | ||
| Q3 25 | $36.2M | $-1.9B | ||
| Q2 25 | $30.1M | $-938.0M | ||
| Q1 25 | $8.4M | $-79.0M | ||
| Q4 24 | $32.6M | $7.0M | ||
| Q3 24 | $68.1M | $-494.0M | ||
| Q2 24 | $78.5M | $-123.0M |
毛利率ACHCRIG
| Q1 26 | — | — | ||
| Q4 25 | — | 42.0% | ||
| Q3 25 | — | 43.2% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 38.0% |
营业利润率ACHCRIG
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 23.0% | ||
| Q3 25 | 4.7% | -163.1% | ||
| Q2 25 | 5.8% | -97.6% | ||
| Q1 25 | 1.7% | 7.1% | ||
| Q4 24 | 4.9% | 13.7% | ||
| Q3 24 | 12.1% | -51.2% | ||
| Q2 24 | 13.4% | -6.9% |
净利率ACHCRIG
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 2.4% | ||
| Q3 25 | 4.3% | -187.1% | ||
| Q2 25 | 3.5% | -94.9% | ||
| Q1 25 | 1.1% | -8.7% | ||
| Q4 24 | 4.2% | 0.7% | ||
| Q3 24 | 8.4% | -52.1% | ||
| Q2 24 | 9.9% | -14.3% |
每股收益（稀释后）ACHCRIG
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.13 | ||
| Q3 25 | $0.40 | $-2.00 | ||
| Q2 25 | $0.33 | $-1.06 | ||
| Q1 25 | $0.09 | $-0.11 | ||
| Q4 24 | $0.36 | $-0.14 | ||
| Q3 24 | $0.74 | $-0.58 | ||
| Q2 24 | $0.85 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $620.0M |
| 总债务越低越好 | $2.5B | $5.2B |
| 股东权益账面价值 | $2.0B | $8.1B |
| 总资产 | $5.5B | $15.6B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.64× |
8季度趋势，按日历期对齐
现金及短期投资ACHCRIG
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $620.0M | ||
| Q3 25 | $118.7M | $833.0M | ||
| Q2 25 | $131.4M | $377.0M | ||
| Q1 25 | $91.2M | $263.0M | ||
| Q4 24 | $76.3M | $560.0M | ||
| Q3 24 | $82.1M | $435.0M | ||
| Q2 24 | $77.2M | $475.0M |
总债务ACHCRIG
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $5.2B | ||
| Q3 25 | $2.3B | $4.8B | ||
| Q2 25 | $2.3B | $5.9B | ||
| Q1 25 | $2.2B | $5.9B | ||
| Q4 24 | $2.0B | $6.2B | ||
| Q3 24 | $1.9B | $6.5B | ||
| Q2 24 | $1.8B | $6.8B |
股东权益ACHCRIG
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $8.1B | ||
| Q3 25 | $3.1B | $8.1B | ||
| Q2 25 | $3.1B | $9.4B | ||
| Q1 25 | $3.0B | $10.2B | ||
| Q4 24 | $3.1B | $10.3B | ||
| Q3 24 | $3.0B | $10.2B | ||
| Q2 24 | $3.0B | $10.7B |
总资产ACHCRIG
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $15.6B | ||
| Q3 25 | $6.4B | $16.2B | ||
| Q2 25 | $6.3B | $17.8B | ||
| Q1 25 | $6.1B | $19.0B | ||
| Q4 24 | $6.0B | $19.4B | ||
| Q3 24 | $5.9B | $19.5B | ||
| Q2 24 | $5.7B | $20.3B |
负债/权益比ACHCRIG
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.64× | ||
| Q3 25 | 0.74× | 0.60× | ||
| Q2 25 | 0.74× | 0.63× | ||
| Q1 25 | 0.72× | 0.58× | ||
| Q4 24 | 0.64× | 0.60× | ||
| Q3 24 | 0.62× | 0.64× | ||
| Q2 24 | 0.62× | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $349.0M |
| 自由现金流经营现金流 - 资本支出 | — | $321.0M |
| 自由现金流率自由现金流/营收 | — | 30.8% |
| 资本支出强度资本支出/营收 | — | 2.7% |
| 现金转化率经营现金流/净利润 | 13.78× | 13.96× |
| 过去12个月自由现金流最近4个季度 | — | $626.0M |
8季度趋势，按日历期对齐
经营现金流ACHCRIG
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $349.0M | ||
| Q3 25 | $73.2M | $246.0M | ||
| Q2 25 | $133.5M | $128.0M | ||
| Q1 25 | $11.5M | $26.0M | ||
| Q4 24 | $116.7M | $206.0M | ||
| Q3 24 | $163.1M | $194.0M | ||
| Q2 24 | $171.1M | $133.0M |
自由现金流ACHCRIG
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $321.0M | ||
| Q3 25 | $-63.0M | $235.0M | ||
| Q2 25 | $-34.2M | $104.0M | ||
| Q1 25 | $-163.2M | $-34.0M | ||
| Q4 24 | $-86.8M | $177.0M | ||
| Q3 24 | $-27.1M | $136.0M | ||
| Q2 24 | $16.9M | $49.0M |
自由现金流率ACHCRIG
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 30.8% | ||
| Q3 25 | -7.4% | 22.9% | ||
| Q2 25 | -3.9% | 10.5% | ||
| Q1 25 | -21.2% | -3.8% | ||
| Q4 24 | -11.2% | 18.6% | ||
| Q3 24 | -3.3% | 14.3% | ||
| Q2 24 | 2.1% | 5.7% |
资本支出强度ACHCRIG
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.7% | ||
| Q3 25 | 16.0% | 1.1% | ||
| Q2 25 | 19.3% | 2.4% | ||
| Q1 25 | 22.7% | 6.6% | ||
| Q4 24 | 26.3% | 3.0% | ||
| Q3 24 | 23.3% | 6.1% | ||
| Q2 24 | 19.4% | 9.8% |
现金转化率ACHCRIG
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 13.96× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 29.43× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
RIG
| Ultra Deepwater Floaters | $433.0M | 42% |
| BR | $236.0M | 23% |
| Other Geographical | $211.0M | 20% |
| Harsh Environment Floaters | $163.0M | 16% |
